Bionor Pharma Now Covered by Edison Investment Research (BIONOR)
Analysts at Edison Investment Research began coverage on shares of Bionor Pharma (OL:BIONOR) in a research report issued to clients and investors on Thursday, Stock Ratings Network.com reports. The firm set a $4.00 price target on the stock.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.